HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rafal, R. D. Articles by Grimm, R. J. Search for Related Content PubMed PubMed Citation Articles by Rafal, R. D. Articles by Grimm, R. J.

Progressive supranuclear palsy

Functional analysis of the response to methysergide and antiparkinsonian agents

Department of Neurology, the Cognitive Neuropsychology Laboratory (Dr. Rafal) and the Neurological Sciences Institute (Dr. Grimm), Good Samaritan Hospital and Medical Center, Portland, OR

Address correspondence and reprint requests to Dr. Rafal. Department of Neurology. Good Samaritan Hospital and Medical Center, Portland, OR 97210

Twelve patients with progressive supranuclear palsy were treated with methysergide; the response was monitored with videotaped examination, electrooculography, and psychometric assessment. Used alone and with antiparkinsonian agents, methysergide improved the quality of life in eight patients for 6 months to 2 years. Benefits were especially dramatic in four patients with severe dysphagia. The disorder of visually guided behavior included abnormal orienting responses, visuosocial expression and regard, and visual search. Mesencephalic visuomotor centers appear to be important not only in control of ocular motility but also in the elaboration of visually guided behavior and the orienting of spatial attention.

This article has been cited by other articles:

				K. Kompoliti, C. G. Goetz, I. Litvan, K. Jellinger, and M. Verny Pharmacological Therapy in Progressive Supranuclear Palsy Arch Neurol, August 1, 1998; 55(8): 1099 - 1102. [Abstract] [Full Text] [PDF]